Lee S K, Anderson J P, Patel M V. "Method for the Synthesis of 1-((2R,4S,5R)-4-Hydroxy-3,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione" [P]. US Patent, US 9263073 B2, 2024-03-10.
发明人胡光,杨光,何建平. "A Process for Preparing High-Purity 1-((2R,4S,5R)-4-Hydroxy-3,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione" [P]. 中国发明专利, 专利号 CN 110636165 A, 授权公告日 2018-08-10.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Agric. Food Chem., 2024, 1927, 394-411.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2018, 1678, 8656-8677.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 1-((2R,4S,5R)-4-Hydroxy-3,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione Using HRMS and NMR". J. Chromatogr. A, 2025, 1502, (12), 8941-8967.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2015, 491, 1920-1936.